PublizoomBiosimilar Collaborations Ireland Limited
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 2
- Amount won alone
- €354,584 excl. VAT
- Shared contracts
- 1 (multi-supplier framework agreements)
- Period
- 1 August 2024 – 12 November 2025
Its main clients
- UZ Leuven · 1 contract
- AZ Sint-Lucas Brugge vzw · 1 contract
Where and what
Supplies · 2
Flemish Brabant · 1 West Flanders · 1
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 19 May 2029 re-tender around November 2028 |
Leveren van Trastuzumab en Rituximab voor intraveneus gebruik
UZ Leuven framework agreement |
Celltrion Healthcare Netherlands B.V. BIOSIMILAR COLLABORATIONS IRELAND LIMITED Pfizer sandoz 3 bids received |
€4,264,649 |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 12/11/2025 | Leveren van Trastuzumab en Rituximab voor intraveneus gebruik | UZ Leuven | €4,264,649 shared by 4 |
| 01/08/2024 | Raamovereenkomst voor de levering van Bevacizumab | AZ Sint-Lucas Brugge vzw | €354,584 |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.